A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea | MicrobiomeTrials← Back to trialsNCT05733104
A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-02-19Est. Completion: 2029-09-28
Enrollment target: 600 participants Locations- Pfizer, Seoul, Gangnam-gu, South Korea
Other microbiome trials you might be interested in
Laparoscopic AppendectomyComplicated AppendicitisPeriappendicular Abscess
To evaluate whether a postoperative therapeutic strategy, Fast Track, aimed at shortening hospital stay in pediatric pat…
Barcelona, SpainEst. completion Jun 2028
SBP - Spontaneous Bacterial Peritonitis
Spontaneous bacterial peritonitis (SBP) is a life-threatening complication of liver cirrhosis characterized by infection…
Multiple LocationsEst. completion Sep 1, 2027